The program begins with a discussion on the everyday challenges eye care professionals face in recognizing subtle signs of ...

Delivered quarterly XDEMVY® net sales of approximately $119 million, up approximately 147% year-over-yearWeekly multi-patient prescribers grew ...

The dosage of Xdemvy (lotilaner ophthalmic solution) for Demodex blepharitis is typically 1 drop per eye twice daily for 6 weeks. It’s important to take the Xdemvy dosage your doctor prescribes.

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in a fireside chat at the ...

Management expects Q4 XDEMVY net product sales in the range of $140 million to $145 million, with annual revenue guidance at $440 million to $445 million. Farrow added, "We also expect inventory ...

For ocular rosacea, dermatologists can do more than hand off patients to ophthalmology by asking the right questions and ...

IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that it will host a live webcast at 1:30 p.m. PT / 4:30 p.m. ET on Tuesday, November 4, ...

Tarsus Pharmaceuticals, Inc. ( ($TARS) ) has released its Q3 earnings. Here is a breakdown of the information Tarsus Pharmaceuticals, Inc.

All eyes are on Tarsus Pharmaceuticals Inc as the company prepares to release its quarterly earnings after market close today ...

Opus Genetics has completed a Type B Regenerative Medicine Advanced Therapy (RMAT) meeting with the US Food and Drug ...

Vivek Subbiah, MD, says artificial intelligence (AI) should assist clinicians in precision oncology, not replace human decision-making. Artificial intelligence (AI) should assist clinicians in ...

Actinomyces and CCL11 are identified as significant contributors to idiopathic pulmonary fibrosis through the gut-lung axis. Mendelian randomization implicated 12 gut microbiota taxa and 8 ...